KTTA Pasithea Therapeutics Corp. logo

KTTA Pasithea Therapeutics Corp.

Healthcare
$0.69+0.00%OpenMarket Cap: $5.1M

As of 2026-05-26

Insider Statistics (Q2 2024)

Acquisitions

2

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+3,500

Shares Acquired

3,500

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 05STEINMAN LAWRENCEdirectorSell152,783$0.84152,783
Tue May 05Schneiderman Daniel Hofficer: Chief Financial OfficerSell1,129,323$0.841,129,323
Tue May 05Novak Alfred JdirectorSell152,783$0.84152,783
Tue May 05Marques Tiagodirector, officer: Chief Executive OfficerSell1,756,069$0.841,756,069
Tue May 05Leahy EmerdirectorSell152,783$0.84152,783
Tue May 05Krishnan Kartikofficer: Chief Medical OfficerSell1,129,323$0.841,129,323
Tue May 05Krishnan KartikofficerSell0$0.000
Tue May 05Dumesnil SimondirectorSell152,783$0.84152,783
Fri Apr 17Coastlands Capital LP10 percent ownerSell11,233,334$0.000
Fri Apr 17Coastlands Capital LP10 percent ownerSell0$0.003,735,035
Mon Dec 01STEINMAN LAWRENCEdirectorBuy133,333$0.75199,691
Mon Dec 01Schneiderman Daniel Hofficer: Chief Financial OfficerSell26,667$0.7526,667
Mon Dec 01Marques Tiagodirector, officer: Chief Executive OfficerBuy33,333$0.7573,334
Mon Dec 01Leahy EmerdirectorSell33,333$0.7533,333
Mon Dec 01Dumesnil SimondirectorBuy33,333$0.7535,833